Corneal Blindness clinical trials at UC Irvine
1 research study open to new patients
open to eligible people ages 22-80
To evaluate the safety and probable benefit of the KeraKlear Non-Penetrating Keratoprosthesis when implanted in an eye with corneal opacity that is at high risk of complications with PK.
Irvine, California and other locations